Goran Mitulović: Proteomics and Mass Spectroscopy Identified The Cause of VITT
Goran Mitulović, Senior Application Development Scientist (Field based) at Bruker Daltonics, shared on LinkedIn about a recent article by Jing Jing Wang et al, published in NEJM:
”Do you remember CoVID, the vaccines, and the particular issues with the Astrazeneca and Jonson and Jonson vaccines?
Well, groundbreaking research was just published, and proteomics and mass spectroscopy helped identify the cause of VITT (vaccine-induced immune thrombocytopenia and thrombosis).”
Title: Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Authors: Jing Jing Wang, Linda Schönborn, Theodore E. Warkentin, Luisa Müller, Thomas Thiele, Lena Ulm, Uwe Völker, Sabine Ameling, Sören Franzenburg, Lars Kaderali, Ana Tzvetkova, Alex Colella, Tim Chataway, Chee Wee Tan, Bridie Armour, Alexander Troelnikov, Lucy Rutten, James McCluskey, Roland Zahn
Read the Full Article on NEJM
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 12, 2026, 11:14Leonardo Roever: CHR as a Composite Biomarker for Stroke Risk Stratification
-
Feb 12, 2026, 11:10Filippo Cademartiri: Can AI Reduce Diagnostic Errors in Low-Resource Settings?
-
Feb 12, 2026, 11:06Murad Ali: An Important Marker of Active Clot Formation and Fibrinolysis
-
Feb 12, 2026, 11:02Right Chukwuneme: Daltaparin vs Apixaban – Efficacy or Safety Paradox?
-
Feb 12, 2026, 10:57Muntadhar Al Moosawi Gives A Talk on Chromogenic FVIII in Hemophilia A at WHX Labs Dubai
-
Feb 12, 2026, 10:52Dario Bongiovanni: Meeting Wrap-Up of ESC Heart and Stroke and EuroThrombosis 2025
-
Feb 12, 2026, 10:40Nikolaos Kotsiou: Honored to Represent the Hemophilia Center of Northern Greece at EAHAD 2026
-
Feb 11, 2026, 17:00A Major Step Forward for the Global Bleeding Disorders Community – Haemophilia Foundation Australia
-
Feb 11, 2026, 16:47Pall T. Onundarson and Mandeep Mehra on Diverse Approaches to Anticoagulation in LVAD Patients